reference/33151086

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33151086

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural
endingPage	181
issn	0169-5002
pageRange	174-181
publicationName	Lung cancer (Amsterdam, Netherlands)
startingPage	174
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e115b0ac8a52d98ddce5ca4da4e0a4a6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_19acaebcc0289dc40a95ec6351788922 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ac8c5c8d3f9dce3c36935ab0d4b87707 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_55a124b09e408b0231cfe8ae40327d35
bibliographicCitation	Zhao D, Mambetsariev I, Li H, Chen C, Fricke J, Fann P, Kulkarni P, Xing Y, Lee PP, Bild A, Massarelli E, Koczywas M, Reckamp K, Salgia R. Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors. Lung Cancer. 2020 Aug;146():174–81. doi: 10.1016/j.lungcan.2020.05.025.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad7bb8e9d0b7013d413e319c35ae58dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8216eaf0a2fe9de9dab84ef31d462818 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_739e4f70e037ad9df13963db0b775c92 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9abe1ffb7ce65bfac9d6d7a5a77e995f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_baf5fde5b3f08d5bac992536837c2652 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a16616ae825637762662c139486124a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c840fb6964b076d4557fafd6027df1c3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd6d164b52eb10c7fb5e62fca4a24ccb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92735a7182710b7de41c726b347ce6d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1adda9493738db7f0c0d805ea8c735ca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b741c1bab3d0b058815b40a7b61d170f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e958dc3396a3fea24f76c7af1dc7050 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee218c5d91492c4f3db59760d9bdabc0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ea76b90ea2ed48a46f2aec795fac36a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7066-9058
date	202008
identifier	https://doi.org/10.1016/j.lungcan.2020.05.025 https://pubmed.ncbi.nlm.nih.gov/32554069 https://pubmed.ncbi.nlm.nih.gov/PMC8158847
isPartOf	https://portal.issn.org/resource/ISSN/0169-5002 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8534
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors
discusses	http://id.nlm.nih.gov/mesh/M0585694 http://id.nlm.nih.gov/mesh/M0022149
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D008175Q000235 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D002289Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D014408 http://id.nlm.nih.gov/mesh/D000077594 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9e97a47eb9e6c78b61149c74e7330d8f http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9e90d4e44a80e67eaffbf3ea1e598132 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID310859

Showing number of triples: 1 to 54 of 54.